(3S,4S)-4-([5-(2,4-Difluoro-phenyl)-isoxazole-3-carbonyl]-amino)-1-(2-methoxy-ethyl)piperidine-3-carboxylic acid (1-pyrimidin-2-yl-cyclopropyl)-amide

ID: ALA4757151

PubChem CID: 141678168

Max Phase: Preclinical

Molecular Formula: C26H28F2N6O4

Molecular Weight: 526.54

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COCCN1CC[C@H](NC(=O)c2cc(-c3ccc(F)cc3F)on2)[C@@H](C(=O)NC2(c3ncccn3)CC2)C1

Standard InChI:  InChI=1S/C26H28F2N6O4/c1-37-12-11-34-10-5-20(18(15-34)23(35)32-26(6-7-26)25-29-8-2-9-30-25)31-24(36)21-14-22(38-33-21)17-4-3-16(27)13-19(17)28/h2-4,8-9,13-14,18,20H,5-7,10-12,15H2,1H3,(H,31,36)(H,32,35)/t18-,20-/m0/s1

Standard InChI Key:  PIQMJKKBIXUIDS-ICSRJNTNSA-N

Molfile:  

 
     RDKit          2D

 38 42  0  0  0  0  0  0  0  0999 V2000
   17.4004  -30.5167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9959  -31.2266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8129  -31.2220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3137  -27.5465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0241  -27.1426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7658  -27.4765    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.3167  -26.8729    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.9128  -26.1624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1124  -26.3270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2477  -25.4193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0621  -25.3405    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3995  -24.5970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9234  -23.9317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1062  -24.0148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7726  -24.7585    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2597  -23.1869    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   16.9595  -24.8407    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   15.6087  -27.1331    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.3082  -28.3636    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.5977  -28.7675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8941  -28.3514    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1858  -28.7518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1761  -29.5693    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.8809  -29.9848    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5954  -29.5828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3002  -29.9964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0108  -29.5927    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.2945  -30.8135    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.9936  -32.0443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2803  -32.4442    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.2742  -33.2606    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9796  -33.6750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6925  -33.2670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6951  -32.4519    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.4642  -29.9704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4556  -30.7876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1590  -31.2036    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.1504  -32.0207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  1  3  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  8 10  1  0
 13 16  1  0
 15 17  1  0
  4 18  2  0
  4 19  1  0
 20 19  1  6
 20 21  1  0
 20 25  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  1
 26 27  2  0
 26 28  1  0
 28  2  1  0
  2 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 29  1  0
 23 35  1  0
 35 36  1  0
 36 37  1  0
 37 38  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4757151

    ---

Associated Targets(Human)

ACKR3 Tchem C-X-C chemokine receptor type 7 (1102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 526.54Molecular Weight (Monoisotopic): 526.2140AlogP: 2.28#Rotatable Bonds: 9
Polar Surface Area: 122.48Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.89CX Basic pKa: 8.13CX LogP: 1.37CX LogD: 0.56
Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.44Np Likeness Score: -1.69

References

1. Richard-Bildstein S,Aissaoui H,Pothier J,Schäfer G,Gnerre C,Lindenberg E,Lehembre F,Pouzol L,Guerry P.  (2020)  Discovery of the Potent, Selective, Orally Available CXCR7 Antagonist ACT-1004-1239.,  63  (24): [PMID:33314938] [10.1021/acs.jmedchem.0c01588]

Source